Loading...

Home >> Blog >> Suraksha Diagnostic IPO: Price, Date, Overview, And GMP

Suraksha Diagnostic IPO: Price, Date, Overview, And GMP

  


Suraksha Diagnostic IPO-Complete Overview

Suraksha Diagnostic IPO a Mainboard IPO is a book-built issue of Rs.846.25 crore (19,189,330 Cr Shares) by Suraksha Diagnostic Limited, which has been providing pathology, radiological testing, and medical consultant services since 2005 that is its establishment year.

By June 30, 2024, West Bengal, Bihar, Assam, and Meghalaya have expanded their coverage to other states with a central reference laboratory backed by eight satellite laboratories and 215 customer touchpoints, including 49 diagnostic centers and 166 sample collection centers.

In Fiscal 2024, the company's market share in Eastern India's diagnostic services market was from 1.15 to 1.30%

Under one roof, the company brings medical consultation services online and offline to 44 diagnostic centers, which house 120 polyclinics housing more than 750 doctors.

The operational efficiency of the above diagnostic centers is further complemented by the technology platforms and systems that the company has mentioned above for streamlining such as its Laboratory Information Management System (LIMS), fully integrated Radiology Information System (RIS), Picture Archive Communication System (PACS), and Enterprise Resource Planning System (ERP).

The Company also provides Vaccination Services and personalized Testing Packages for Disease Prediction/Early Detection. It uses digital pathology and Artificial Intelligence for blood tests. Digital Platforms are used for radiology reporting enabling all diagnostic centres for case reporting and hence reducing turnaround time significantly.

This new IPO is to be launched on 29 November 2024, and the initial public offering of this upcoming IPO will end on 03 December 2024.

Detailed Video

Suraksha Diagnostic IPO Details

The Rs.846.25 crore Suraksha Clinic and Diagnostic IPO comprises a wholly offer for sale (OFS) of 1.92 crore Shares. The IPO listing date is on December 06, 2024. Suraksha Diagnostic IPO share price is Rs.420 to Rs.441.

If you want to apply for the IPO,  Click Here to open a Demat Account.

Company Financial

The company’s revenue grew by 14.75% and PAT increased by 281.32% between FYs ended 31 March 2024 and 31 March 2023.

(Amount in Crore)

Period

30 Jun 2024

31 Mar 2024

31 Mar 2023

Total Assets 

314.20

300.21

281.20

Total Revenue

61.85

222.26

193.69

PAT

7.67

23.13

6.07

Net Worth

187.05

179.41

155.93

Total Reserves and Surplus

176.80

170.88

147.40

Total Borrowings

7.57

8.64

14.01

 

Cash Flows

(Amount in million)

Net Cash Flow In Multiple Activities

30 Jun 2024

FY2024

FY2023

Net Cash Flow Operating Activities

183.52 

604.84

440.96

Net Cash Flow Investing Activities

-100.65

-349.96

-207.95

Net Cash Flow Financing Activities

-63.86

-251.30

-243.28

 

Service-wise Revenue Bifurcation

(Values in millions)

Particular

30 Jun 2024

FY2024

FY2023

Radiology 

282.52 

1,006.72

841.31

Pathology 

302.14

1,165.81 

1,024.57 

Doctor Consultation

22.45

10.62 

-

Covid tests 

0.21 

3.94

35.46 

Total 

607.32

2,187.09 

1,901.34 

 

Geography-wise Revenue Bifurcation

(Values in millions)

Particular

FY2024

North 24 Parganas

1,073.59

Kolkata 10

529.96

South 24 Parganas 

77

Hooghly 

60.33

Howrah 

16.33

Jalpaiguri 

32.76

Darjeeling 

69.61

Nadia 

83.84

Bardhaman

39.80

Purba Mednipore 

14.72

Cooch Behar 

0.28

 

 

The Objective of the Issue

All proceeds shall go to the company’s Shares Holders as the offer is completely an OFS.

 

Peers of Suraksha Diagnostic Limited

Company Name

Face Value (Rs.)

EPS (Rs.)

P/E (x)

Dr. Lal PathLabs

10

43.05

77.08

Metropolis Healthcare Ltd.

2

24.95

89.61

Thyrocare Technologies Ltd.

10

13.42

65.52

Vijaya Diagnostic Centre Limited

1

11.62

86.40

 

Evaluation

The IPO price is between Rs.420 to Rs.441 for each Share.

Evaluation of P/E Ratio

Considering the FY ended 31 Mar 2024 with an EPS of Rs.4.43 from the last year, the resulting P/E ratio is 99.54x.  Considering the weighted EPS of Rs.3.27 for the last three years, the P/E ratio is 134.86x.

Comparative Analysis with Listed Peers

The average P/E Ratio of the industry is 79.65x.

 

Particulars

P/E Ratio (x)

Highest 

89.61 

Lowest 

65.52

Average

79.65

In simple words, the P/E ratio of this IPO (99.54x), compared with the industry’s average P/E of 79.65x, has an overvaluation (on a P/E ratio basis only). Hence the price of the Share seems aggressively priced for the investors when considered based on the average P/E ratio of the industry.
 

IPO's Strengths 

  • Deep internal diagnostics pipeline absorbing the sizable opportunities generated by organized diagnostic chains in fragmented diagnostic services markets of East and Northeast India.

  • The integrated diagnostic service offers pathology plus radiology tests and medical consultant services all from one source.

  • Fully technologically invested in the clinical infrastructure.

  • Top-notch quality that drives up individual consumer business share and high retention.

  • Management with relevant industry experience.

 

IPO’s Weaknesses 

  • Suraksha Clinic and Diagnostic in its RHP mentioned that 95.48% of its revenue from operations in FY24 came from West Bengal. Any impairment of this revenue would be detrimental to the business. The company added that any contraction in business in the region would be detrimental to its business.

  • The company faces competition in India, and the inability to compete with other players in healthcare services may hurt its business.

  • The company is subject to legal liabilities, operational liabilities, reputational liabilities, medical and legal claims, regulatory actions, and all other possible liabilities arising out of healthcare services. It could also become liable for claims of malpractice and medical negligence.

  • It carries out its business with the reliance on information technology systems and third-party platforms and any disruption on the side of third-party platforms may have adverse consequences on their business.

 

 

Suraksha Diagnostic IPO GMP

Suraksha Diagnostic IPO GMP today has not started yet, with a price band of Rs.441, the estimated Suraksha Diagnostic IPO listing price is Rs.441 (as of 26 November 2024).

Suraksha Clinic IPO Timetable (Tentative)

The Suraksha Diagnostic IPO date is from 29 November to 03 December, with IPO allotment on 04 December, and refund initiation on 05 December. The IPO listing date is on 06 December 2024.

Events 

Date

IPO Opening Date

29 November 2024

IPO Closing Date

03 December 2024

IPO Allotment Date 

04 December 2024

Refund Initiation 

05 December 2024

IPO Listing Date

06 December 2024

 

IPO Other Details 

The Suraksha Diagnostic IPO Size is 19,189,330 Shares, with a face value of Rs.2 per Share it will be listed at BSE and NSE.

IPO Opening & Closing date 

29 November 2024 to 03 December 2024

Face Value 

Rs.2 per Share

Issue Price

Rs.420 to Rs.441

Lot Size

34 Shares

Issue Size

19,189,330 Shares (Rs.846.25 Cr)

Offer for Sale 

19,189,330 Shares (Rs.846.25 Cr)

Fresh Issue 

NA

Listing At

BSE, NSE

Issue Type 

Book Built Issue IPO

Registrar 

Kfin Technologies Limited 

 

Suraksha Diagnostic IPO Lot Size

The IPO allows retail investors to invest in a minimum and maximum of 1 Lot (34 Shares) amounting to Rs.14,994 and 13 Lots (442 Shares) amounting to Rs.194,922 respectively, while for HNI investors, the minimum Lot is 14 (476 Shares) amounting to Rs.2,09,916.

Minimum Lot Investment (Retail)

1 Lot

Maximum Lot Investment (Retail) 

13 Lots

S-HNI (Minimum)

14 Lots

S-HNI (Maximum)

66 Lots

B-HNI (Minimum)

67 Lots

 

IPO Reservation

Institutional Share Portion

50%

Retail Investors Share Portion

35%

Non-Institutional Shares Portion

15%

 

Promoters and Management of Suraksha Diagnostic Limited. 

  • Dr. Somnath Chatterjee

  • Ritu Mittal

  • Satish Kumar Verma

Pre-Issue Promoter Shareholding

61.07%

Post-Issue Promoter Shareholding

-

 

IPO Lead Managers

  • ICICI Securities Limited

  • Nuvama Wealth Management Limited

  • SBI Capital Markets Limited

 

Dividend Policy

The company has not paid any dividends in the last three years. 

 

Conclusion

The Suraksha Diagnostics IPO indicates the potential that the organization has to grow within the diagnostics sector, underpinned by strong technological support and a wide service network. Nevertheless, the company is at high stakes concerning its valuations, as well as the high dependency on revenue from West Bengal. Indeed, though the expansion efforts of the company appear to be promising, potential investors will have to critically weigh the competition and financial prospects before putting in their money.

Finowings IPO Analysis

Hope you enjoyed the Finowings IPO Analysis. We tried our best to give every required detail about the company that you should know before applying to the IPO. 

You must consult your financial advisor before making any financial decisions. 

To Apply for the IPO, Click Here.

To Read the Prospectus of the Company Click Here to Download the DRHP.

DISCLAIMER:

DISCLAIMER: NOT any buy or sell recommendation. No investment or trading advice is given. The content is purely for educational and information purposes only. Always discuss with an eligible financial advisor before investing. 

Click Here to stay updated with the Upcoming IPOs.

Want to start Your Journey in stock market trading and investment? Join our Stock Market Class to become a beginner to expert trader! We cover everything from the basics of trading to advanced strategies for picking stocks. Plus, we're offering a special discount for women and students. Don't miss out - enroll now and kickstart your path to success in the stock market!Open a world of Stock Market by Opening a Demat Account with your favorite Broking firm & Get a trading Strategy worth Rs.15,000!

 

Click here to open a Free Demat Account.

Thank You for reading this blog.Hope you loved the IPO analysis. Please Comment Below with your feedback because Your feedback motivates us to deliver more such content.

Follow MUKUL AGRAWAL for the latest IPO news and reviews. You can connect with us on social media platforms like TwitterFacebook, and Instagram. You can also subscribe to our YouTube Channel for the latest videos of the stock.

b



Frequently Asked Questions

+

 Ritu Mittal and Somnath Chatterjee are the company’s founders.

+

As per the information available on the internet, it provides reliable and accurate diagnostic services to its clients.

+

Rs.2.19 Bn for FY24 is the company’s revenue.

 



Liked What You Just Read? Share this Post:




Viewer's Thoughts

Any Question or Suggestion

Post your Thoughts


IPO

Related Blogs

Mamata Machinery IPO

IPO | 13-12- 2024

Mamata Machinery IPO: Price, G...

Explore Mamata Machinery IPO details, including price, GMP, allotment, and listing. Get key financials and insights on t...

Continue Reading
Transrail Lighting IPO

IPO | 12-12- 2024

Transrail Lighting IPO : Date,...

Transrail Lighting IPO: Get details on date, price, GMP, and more. Stay updated on this upcoming IPO with key insights a...

Continue Reading
International Gemological Institute IPO

IPO | 12-12- 2024

International Gemological Inst...

Stay updated on the International Gemological Institute IPO: launch date, price, GMP, valuation, and more. Explore this ...

Continue Reading
Inventurus Knowledge Solutions

IPO | 11-12- 2024

Inventurus Knowledge Solutions...

Get a complete overview of Inventurus Knowledge Solutions IPO. Check GMP today, IPO dates, price band, financials, stren...

Continue Reading
Sai Life Sciences IPO

IPO | 11-12- 2024

Sai Life Sciences IPO: Date, P...

Sai Life Sciences IPO opening date is 11 Dec. Check IPO price, listing date, allotment status, GMP etc with company stre...

Continue Reading
Mobikwik IPO

IPO | 07-12- 2024

Mobikwik IPO: Date, Price, GMP...

Get a complete overview of the Mobikwik IPO, including dates, price band, GMP, and valuation. Learn all key details befo...

Continue Reading
for a Chance to Learn Free Technical Analysis
Subscribe on
YouTube
Follow us on
Instagram
Follow Us on
Twitter
Like Us on
Facebook